1	Es	ser	VSIP3S0	-	-	0-2	530(0)_ANS_clinical_caseMIR	SENT1	-	-
2	un	un		C0205447_1	calificador_1	3-5	530(0)_ANS_clinical_caseMIR	SENT1	-	-
3	brote	brote	NCMS000	-	-	6-11	530(0)_ANS_clinical_caseMIR	SENT1	-	-
4	de	de	SPS00	C0332285	atributo	12-14	530(0)_ANS_clinical_caseMIR	SENT1	-	-
5	artritis	artritis	NCFN000	C0003873_1	trastorno_1	15-23	530(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
6	reumatoide	reumatoide	AQ0CS0	C0003873_2	trastorno_2	24-34	530(0)_ANS_clinical_caseMIR	SENT1	B-Calificador	-
7	insuficientemente	insuficientemente	RG	-	-	35-52	530(0)_ANS_clinical_caseMIR	SENT1	-	-
8	controlado	controlar	VMP00SM	-	-	53-63	530(0)_ANS_clinical_caseMIR	SENT1	-	-
9	.	.	Fp	-	-	63-64	530(0)_ANS_clinical_caseMIR	SENT1	-	-

1	Debe	deber	VMIP3S0	-	-	65-69	530(0)_ANS_clinical_caseMIR	SENT2	-	-
2	aumentar	aumentar	VMN0000	-	-	70-78	530(0)_ANS_clinical_caseMIR	SENT2	-	-
3	se	se	PP3CN000	-	-	78-80	530(0)_ANS_clinical_caseMIR	SENT2	-	-
4	la	el	DA0FS0	-	-	81-83	530(0)_ANS_clinical_caseMIR	SENT2	-	-
5	dosis	dosis	NCFN000	-	-	84-89	530(0)_ANS_clinical_caseMIR	SENT2	-	-
6	de	de	SPS00	C0332285	atributo	90-92	530(0)_ANS_clinical_caseMIR	SENT2	-	-
7	prednisona	prednisona	NCFS000	C0032952	sustancia	93-103	530(0)_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
8	o	o	CC	-	-	104-105	530(0)_ANS_clinical_caseMIR	SENT2	-	-
9	asociar	asociar	VMN0000	-	-	106-113	530(0)_ANS_clinical_caseMIR	SENT2	-	-
10	un	un		C0205447_1	calificador_1	114-116	530(0)_ANS_clinical_caseMIR	SENT2	-	-
11	antiinflamatorio	antiinflamatorio	NC00AO0	-	-	117-133	530(0)_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	vigilando	vigilar	VMG0000	-	-	134-143	530(0)_ANS_clinical_caseMIR	SENT2	-	-
13	la	el	DA0FS0	-	-	144-146	530(0)_ANS_clinical_caseMIR	SENT2	-	-
14	función	función	NCFS000	C0232804_1	entidad_observable_1	147-154	530(0)_ANS_clinical_caseMIR	SENT2	-	-
15	renal	renal	AQ0CS0	C0232804_2	entidad_observable_2	155-160	530(0)_ANS_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
16	.	.	Fp	-	-	161-162	530(0)_ANS_clinical_caseMIR	SENT2	-	-

